C/EBPβ, mostly observed in oestrogen receptor‐negative and highly proliferative and metastatic mammary tumours, appears to be a contributor to tumorigenesis in breast and is usually associated with a poor prognosis.14 Here, CEBPB is linked to breast cancer.